After myocardial infarction in adult mice, combinatorial therapy with p38 inhibitor and FGF1 has been shown to induce cardiomyocyte proliferation and cardiac tissue regeneration, reduce scar formation and improve cardiac function (90). The gene discussed is FGF1; the disease is myocardial infarction.